Cases & Deals

  • Home
  • Practices
  • Stallergenes Greer obtains revolving credit facility from UBS

Share

Stallergenes Greer obtains revolving credit facility from UBS

December 2016

Client(s) Stallergenes Greer plc

Jones Day represented Stallergenes Greer plc, a global biopharmaceutical company specializing in treatments for respiratory allergies, in connection with a new revolving credit facility provided by UBS Switzerland AG.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.